Self-Carrier Nanoagonist Enabling Positive Feedback Regulation of Cuproptosis-Immunity for Potent Antitumor Therapy.

Cuproptosis-based immunotherapy shows significant potential in the treatment of cancer. However, its therapeutic effectiveness is hampered by inefficient copper delivery, poor targeting, tumor metabolic reprogramming, and the immunosuppressive tumor…

Preview only. Read the full abstract at the source